Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19370 | 508 | 48.2 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
518 | 3 | ANGIOGENESIS//RETINOPATHY OF PREMATURITY//ENDOSTATIN | 20826 |
361 | 2 | ANGIOGENESIS//ENDOSTATIN//VEGF | 17372 |
19370 | 1 | VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TUMOR ENDOTHELIAL CELLS | 508 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VASCULOGENIC MIMICRY | authKW | 9517020 | 37% | 83% | 190 |
2 | TIANJIN CANC HOSP | address | 516460 | 8% | 22% | 39 |
3 | TUMOR ENDOTHELIAL CELLS | authKW | 357832 | 3% | 37% | 16 |
4 | VASCULAR MIMICRY | authKW | 324575 | 2% | 60% | 9 |
5 | ORAL PATHOL BIOL | address | 310176 | 3% | 30% | 17 |
6 | TIANJIN GEN HOSP | address | 310013 | 3% | 37% | 14 |
7 | VASCULOGENIC MIMICRY VM | authKW | 240432 | 1% | 100% | 4 |
8 | FRONTIER UNIT | address | 214668 | 1% | 71% | 5 |
9 | TUMOR PLASTICITY | authKW | 187833 | 1% | 63% | 5 |
10 | EXPT DIAG BIOTHER Y TUMORS | address | 180324 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 6014 | 56% | 0% | 284 |
2 | Pathology | 701 | 11% | 0% | 56 |
3 | Medicine, Research & Experimental | 446 | 12% | 0% | 61 |
4 | Cell Biology | 323 | 15% | 0% | 74 |
5 | Cell & Tissue Engineering | 29 | 1% | 0% | 4 |
6 | Hematology | 24 | 3% | 0% | 15 |
7 | Peripheral Vascular Diseases | 11 | 2% | 0% | 11 |
8 | Pharmacology & Pharmacy | 11 | 6% | 0% | 28 |
9 | Dermatology | 9 | 2% | 0% | 8 |
10 | Biochemistry & Molecular Biology | 9 | 9% | 0% | 44 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TIANJIN CANC HOSP | 516460 | 8% | 22% | 39 |
2 | ORAL PATHOL BIOL | 310176 | 3% | 30% | 17 |
3 | TIANJIN GEN HOSP | 310013 | 3% | 37% | 14 |
4 | FRONTIER UNIT | 214668 | 1% | 71% | 5 |
5 | EXPT DIAG BIOTHER Y TUMORS | 180324 | 1% | 100% | 3 |
6 | TIANJIN HOP 2 | 120216 | 0% | 100% | 2 |
7 | MERCI EA 3829 | 87425 | 1% | 36% | 4 |
8 | INNOVAT NANOMED | 83929 | 2% | 16% | 9 |
9 | RENAL GENITOURINARY SURG | 83579 | 2% | 13% | 11 |
10 | BADAN TRANSLACYJNYCH BIOL MOL | 80143 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOTARGET | 2796 | 5% | 0% | 24 |
2 | MELANOMA RESEARCH | 1665 | 1% | 0% | 7 |
3 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 1463 | 2% | 0% | 8 |
4 | AMERICAN JOURNAL OF PATHOLOGY | 1353 | 3% | 0% | 17 |
5 | ANGIOGENESIS | 1305 | 0% | 2% | 1 |
6 | CANCER RESEARCH | 1089 | 5% | 0% | 27 |
7 | CANCER SCIENCE | 1079 | 2% | 0% | 8 |
8 | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 1063 | 1% | 0% | 7 |
9 | CANCER BIOLOGY & THERAPY | 1038 | 1% | 0% | 7 |
10 | MEDICAL ONCOLOGY | 886 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VASCULOGENIC MIMICRY | 9517020 | 37% | 83% | 190 | Search VASCULOGENIC+MIMICRY | Search VASCULOGENIC+MIMICRY |
2 | TUMOR ENDOTHELIAL CELLS | 357832 | 3% | 37% | 16 | Search TUMOR+ENDOTHELIAL+CELLS | Search TUMOR+ENDOTHELIAL+CELLS |
3 | VASCULAR MIMICRY | 324575 | 2% | 60% | 9 | Search VASCULAR+MIMICRY | Search VASCULAR+MIMICRY |
4 | VASCULOGENIC MIMICRY VM | 240432 | 1% | 100% | 4 | Search VASCULOGENIC+MIMICRY+VM | Search VASCULOGENIC+MIMICRY+VM |
5 | TUMOR PLASTICITY | 187833 | 1% | 63% | 5 | Search TUMOR+PLASTICITY | Search TUMOR+PLASTICITY |
6 | MOSAIC VESSELS | 135241 | 1% | 75% | 3 | Search MOSAIC+VESSELS | Search MOSAIC+VESSELS |
7 | VASCULOGENIC MIMICRY CHANNELS | 135241 | 1% | 75% | 3 | Search VASCULOGENIC+MIMICRY+CHANNELS | Search VASCULOGENIC+MIMICRY+CHANNELS |
8 | ENDOTHELIUM DEPENDENT VESSELS | 120216 | 0% | 100% | 2 | Search ENDOTHELIUM+DEPENDENT+VESSELS | Search ENDOTHELIUM+DEPENDENT+VESSELS |
9 | KLGR PEPTIDE | 120216 | 0% | 100% | 2 | Search KLGR+PEPTIDE | Search KLGR+PEPTIDE |
10 | MDR1 PHENOTYPE | 120216 | 0% | 100% | 2 | Search MDR1+PHENOTYPE | Search MDR1+PHENOTYPE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | QIAO, LL , LIANG, N , ZHANG, JD , XIE, J , LIU, FJ , XU, DG , YU, XS , TIAN, Y , (2015) ADVANCED RESEARCH ON VASCULOGENIC MIMICRY IN CANCER.JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. VOL. 19. ISSUE 2. P. 315 -326 | 63 | 44% | 24 |
2 | CAO, ZF , BAO, MM , MIELE, L , SARKAR, FH , WANG, ZW , ZHOU, QS , (2013) TUMOUR VASCULOGENIC MIMICRY IS ASSOCIATED WITH POOR PROGNOSIS OF HUMAN CANCER PATIENTS: A SYSTEMIC REVIEW AND META-ANALYSIS.EUROPEAN JOURNAL OF CANCER. VOL. 49. ISSUE 18. P. 3914 -3923 | 43 | 69% | 49 |
3 | LI, SX , MENG, W , GUAN, ZW , GUO, YL , HAN, XZ , (2016) THE HYPOXIA-RELATED SIGNALING PATHWAYS OF VASCULOGENIC MIMICRY IN TUMOR TREATMENT.BIOMEDICINE & PHARMACOTHERAPY. VOL. 80. ISSUE . P. 127 -135 | 51 | 61% | 0 |
4 | YANG, JP , LIAO, YD , MAI, DM , XIE, P , QIANG, YY , ZHENG, LS , WANG, MY , MEI, Y , MENG, DF , XU, L , ET AL (2016) TUMOR VASCULOGENIC MIMICRY PREDICTS POOR PROGNOSIS IN CANCER PATIENTS: A META-ANALYSIS.ANGIOGENESIS. VOL. 19. ISSUE 2. P. 191 -200 | 41 | 64% | 2 |
5 | SPILIOPOULOS, K , PESCHOS, D , BATISTATOU, A , NTOUNTAS, I , AGNANTIS, N , KITSOS, G , (2015) VASCULOGENIC MIMICRY: LESSONS FROM MELANOCYTIC TUMORS.IN VIVO. VOL. 29. ISSUE 3. P. 309 -317 | 46 | 67% | 0 |
6 | CAO, ZF , SHANG, BX , ZHANG, GC , MIELE, L , SARKAR, FH , WANG, ZW , ZHOU, QS , (2013) TUMOR CELL-MEDIATED NEOVASCULARIZATION AND LYMPHANGIOGENESIS CONTRIVE TUMOR PROGRESSION AND CANCER METASTASIS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1836. ISSUE 2. P. 273 -286 | 73 | 37% | 27 |
7 | CHEN, YS , CHEN, ZP , (2014) VASCULOGENIC MIMICRY: A NOVEL TARGET FOR GLIOMA THERAPY.CHINESE JOURNAL OF CANCER. VOL. 33. ISSUE 2. P. - | 35 | 67% | 18 |
8 | ZHANG, JX , QIAO, LL , LIANG, N , XIE, J , LUO, H , DENG, GD , ZHANG, JD , (2016) VASCULOGENIC MIMICRY AND TUMOR METASTASIS.JOURNAL OF BUON. VOL. 21. ISSUE 3. P. 533 -541 | 43 | 55% | 0 |
9 | SUN, W , FAN, YZ , ZHANG, WZ , GE, CY , (2011) A PILOT HISTOMORPHOLOGY AND HEMODYNAMIC OF VASCULOGENIC MIMICRY IN GALLBLADDER CARCINOMAS IN VIVO AND IN VITRO.JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. VOL. 30. ISSUE . P. - | 32 | 80% | 8 |
10 | HIDA, K , MAISHI, N , SAKURAI, Y , HIDA, Y , HARASHIMA, H , (2016) HETEROGENEITY OF TUMOR ENDOTHELIAL CELLS AND DRUG DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 99. ISSUE . P. 140 -147 | 35 | 47% | 3 |
Classes with closest relation at Level 1 |